FdaApplication
ANDA 210335
Identifiers
- fda_app_no: ANDA210335
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LTD |
| application_type | ANDA |
| approval_date | 2019-01-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MEDROXYPROGESTERONE ACETATE | MEDROXYPROGESTERONE ACETATE | 150MG/ML | INJECTABLE;INJECTION |
1 product